Downregulation of miR‑505 Promotes Cell Proliferation, Migration and Invasion, and Predicts Poor Prognosis in Breast Cancer

Oncology Letters - Greece
doi 10.3892/ol.2019.10334
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

miR-96 Promotes Cell Proliferation, Migration and Invasion by Targeting PTPN9 in Breast Cancer

Scientific Reports
Multidisciplinary
2016English

Targeting of TLE3 by miR‑3677 in Human Breast Cancer Promotes Cell Proliferation, Migration and Invasion

Oncology Letters
Cancer ResearchOncology
2019English

Overexpression of microRNA-423-3p Indicates Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion of Lung Cancer

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2019English

MiR-629-3p-induced Downregulation of SFTPC Promotes Cell Proliferation and Predicts Poor Survival in Lung Adenocarcinoma

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

Downregulation of Circulating Exosomal miR-638 Predicts Poor Prognosis in Colon Cancer Patients

Oncotarget
Oncology
2017English

Overexpression of Mir-183 and Mir-494 Promotes Proliferation and Migration in Human Breast Cancer Cell Lines

Oncology Letters
Cancer ResearchOncology
2017English

Upregulation and Hypomethylation of lncRNA AFAP1‑AS1 Predicts a Poor Prognosis and Promotes the Migration and Invasion of Cervical Cancer

Oncology Reports
MedicineCancer ResearchOncology
2019English

Overexpression of LAMC1 Predicts Poor Prognosis and Enhances Tumor Cell Invasion and Migration in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2017English

Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy